---
layout: default
title: "DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery"
---

# DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2505.13940" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2505.13940v2</a>
  <a href="https://arxiv.org/pdf/2505.13940.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2505.13940v2" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2505.13940v2', 'DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Kun Li, Zhennan Wu, Shoupeng Wang, Jia Wu, Shirui Pan, Wenbin Hu

**åˆ†ç±»**: cs.AI, q-bio.BM

**å‘å¸ƒæ—¥æœŸ**: 2025-05-20 (æ›´æ–°: 2025-07-28)

**å¤‡æ³¨**: 29 pages, 8 figures, 2 tables

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºDrugPilotä»¥è§£å†³è¯ç‰©å‘ç°ä¸­çš„å¤šæ¨¡æ€æ•°æ®å¤„ç†é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `è¯ç‰©å‘ç°` `å¤§å‹è¯­è¨€æ¨¡å‹` `è‡ªä¸»æ™ºèƒ½ä½“` `å¤šæ¨¡æ€æ•°æ®` `å‚æ•°åŒ–æ¨ç†` `ç§‘å­¦å†³ç­–` `è‡ªåŠ¨åŒ–ç ”ç©¶` `æ•°æ®é›†æˆ`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰è¯ç‰©å‘ç°æ–¹æ³•åœ¨å¤šæ¨¡æ€æ•°æ®å¤„ç†ã€ä»»åŠ¡è‡ªåŠ¨åŒ–å’Œé¢†åŸŸå·¥å…·æ”¯æŒæ–¹é¢å­˜åœ¨æ˜¾è‘—ä¸è¶³ã€‚
2. DrugPiloté€šè¿‡å‚æ•°åŒ–æ¨ç†æ¶æ„å’Œè®°å¿†æ± è®¾è®¡ï¼Œé›†æˆç»“æ„åŒ–å·¥å…·ä½¿ç”¨ï¼Œæ”¯æŒå¤šé˜¶æ®µç ”ç©¶æµç¨‹ã€‚
3. å®éªŒç»“æœæ˜¾ç¤ºï¼ŒDrugPilotåœ¨å¤šç§åœºæ™¯ä¸‹çš„ä»»åŠ¡å®Œæˆç‡æ˜¾è‘—é«˜äºç°æœ‰æ™ºèƒ½ä½“ï¼Œå±•ç¤ºäº†å…¶å¼ºå¤§çš„åº”ç”¨æ½œåŠ›ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

å¤§å‹è¯­è¨€æ¨¡å‹ï¼ˆLLMsï¼‰ä¸è‡ªä¸»æ™ºèƒ½ä½“çš„ç»“åˆåœ¨ç§‘å­¦å‘ç°ä¸­å…·æœ‰é‡è¦æ½œåŠ›ï¼Œä½†åœ¨è¯ç‰©å‘ç°é¢†åŸŸçš„åº”ç”¨ä»é¢ä¸´å¤šæ¨¡æ€æ•°æ®å¤„ç†ã€ä»»åŠ¡è‡ªåŠ¨åŒ–ä¸è¶³åŠå¯¹é¢†åŸŸç‰¹å®šå·¥å…·æ”¯æŒä¸ä½³ç­‰æŒ‘æˆ˜ã€‚ä¸ºæ­¤ï¼Œæœ¬æ–‡æå‡ºäº†DrugPilotï¼Œä¸€ä¸ªåŸºäºLLMçš„æ™ºèƒ½ä½“ç³»ç»Ÿï¼Œé‡‡ç”¨å‚æ•°åŒ–æ¨ç†æ¶æ„ï¼Œæ—¨åœ¨å®ç°è¯ç‰©å‘ç°ä¸­çš„ç«¯åˆ°ç«¯ç§‘å­¦å·¥ä½œæµç¨‹ã€‚DrugPiloté€šè¿‡é›†æˆç»“æ„åŒ–å·¥å…·ä½¿ç”¨å’Œæ–°é¢–çš„å‚æ•°åŒ–è®°å¿†æ± ï¼Œæ”¯æŒå¤šé˜¶æ®µç ”ç©¶è¿‡ç¨‹ï¼Œèƒ½å¤Ÿå°†å¼‚æ„æ•°æ®è½¬åŒ–ä¸ºæ ‡å‡†åŒ–è¡¨ç¤ºï¼Œæå‡å¤šè½®å¯¹è¯çš„æ•ˆç‡ï¼Œå‡å°‘æ•°æ®äº¤æ¢ä¸­çš„ä¿¡æ¯æŸå¤±ï¼Œå¢å¼ºå¤æ‚ç§‘å­¦å†³ç­–èƒ½åŠ›ã€‚æˆ‘ä»¬æ„å»ºäº†æ¶µç›–å…«ä¸ªæ ¸å¿ƒè¯ç‰©å‘ç°ä»»åŠ¡çš„è¯ç‰©æŒ‡ä»¤æ•°æ®é›†ï¼Œå¹¶åœ¨Berkeleyå‡½æ•°è°ƒç”¨åŸºå‡†ä¸‹ï¼ŒDrugPilotåœ¨ç®€å•ã€å¤šå·¥å…·å’Œå¤šè½®åœºæ™¯ä¸­åˆ†åˆ«è¾¾åˆ°äº†98.0%ã€93.5%å’Œ64.0%çš„ä»»åŠ¡å®Œæˆç‡ï¼Œæ˜¾è‘—è¶…è¶Šäº†ç°æœ‰æœ€å…ˆè¿›çš„æ™ºèƒ½ä½“å¦‚ReActå’ŒLoTã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³è¯ç‰©å‘ç°è¿‡ç¨‹ä¸­å¤šæ¨¡æ€æ•°æ®å¤„ç†æ•ˆç‡ä½ã€ä»»åŠ¡è‡ªåŠ¨åŒ–ç¨‹åº¦ä¸è¶³ä»¥åŠå¯¹é¢†åŸŸç‰¹å®šå·¥å…·æ”¯æŒä¸ä½³çš„é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•åœ¨è¿™äº›æ–¹é¢å­˜åœ¨æ˜¾è‘—çš„å±€é™æ€§ï¼Œå½±å“äº†ç§‘å­¦å†³ç­–çš„æ•ˆç‡å’Œå‡†ç¡®æ€§ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šDrugPilotçš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡å‚æ•°åŒ–æ¨ç†æ¶æ„å’Œè®°å¿†æ± çš„è®¾è®¡ï¼Œé›†æˆå¤šç§å·¥å…·å’Œæ•°æ®æºï¼Œæ”¯æŒå¤æ‚çš„ç§‘å­¦å·¥ä½œæµç¨‹ã€‚è¿™æ ·çš„è®¾è®¡èƒ½å¤Ÿæœ‰æ•ˆåœ°å¤„ç†å¼‚æ„æ•°æ®ï¼Œå¹¶æå‡å¤šè½®å¯¹è¯çš„æ•ˆç‡ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šDrugPilotçš„æ•´ä½“æ¶æ„åŒ…æ‹¬æ•°æ®è¾“å…¥æ¨¡å—ã€å‚æ•°åŒ–è®°å¿†æ± ã€æ¨ç†å¼•æ“å’Œè¾“å‡ºæ¨¡å—ã€‚æ•°æ®è¾“å…¥æ¨¡å—è´Ÿè´£æ¥æ”¶æ¥è‡ªå…¬å…±æºå’Œç”¨æˆ·å®šä¹‰çš„è¾“å…¥ï¼Œè®°å¿†æ± å°†è¿™äº›æ•°æ®è½¬åŒ–ä¸ºæ ‡å‡†åŒ–è¡¨ç¤ºï¼Œæ¨ç†å¼•æ“åˆ™åŸºäºè¿™äº›è¡¨ç¤ºè¿›è¡Œå†³ç­–ï¼Œæœ€ç»ˆè¾“å‡ºç»“æœã€‚

**å…³é”®åˆ›æ–°**ï¼šDrugPilotçš„å…³é”®åˆ›æ–°åœ¨äºå…¶å‚æ•°åŒ–è®°å¿†æ± çš„è®¾è®¡ï¼Œèƒ½å¤Ÿæœ‰æ•ˆå‡å°‘ä¿¡æ¯æŸå¤±ï¼Œå¹¶æ”¯æŒé«˜æ•ˆçš„å¤šè½®å¯¹è¯ã€‚è¿™ä¸€è®¾è®¡ä¸ç°æœ‰æ–¹æ³•ç›¸æ¯”ï¼Œæ˜¾è‘—æå‡äº†æ•°æ®å¤„ç†çš„çµæ´»æ€§å’Œå†³ç­–çš„å‡†ç¡®æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æŠ€æœ¯ç»†èŠ‚ä¸Šï¼ŒDrugPiloté‡‡ç”¨äº†ç‰¹å®šçš„å‚æ•°è®¾ç½®ä»¥ä¼˜åŒ–è®°å¿†æ± çš„æ€§èƒ½ï¼Œå¹¶è®¾è®¡äº†é€‚åº”è¯ç‰©å‘ç°ä»»åŠ¡çš„æŸå¤±å‡½æ•°å’Œç½‘ç»œç»“æ„ï¼Œä»¥ç¡®ä¿åœ¨å¤šç§åœºæ™¯ä¸‹çš„é«˜æ•ˆè¡¨ç°ã€‚å…·ä½“çš„å‚æ•°è®¾ç½®å’Œç½‘ç»œç»“æ„ç»†èŠ‚åœ¨è®ºæ–‡ä¸­è¿›è¡Œäº†è¯¦ç»†æè¿°ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨Berkeleyå‡½æ•°è°ƒç”¨åŸºå‡†æµ‹è¯•ä¸­ï¼ŒDrugPilotåœ¨ç®€å•ã€å¤šå·¥å…·å’Œå¤šè½®åœºæ™¯ä¸‹çš„ä»»åŠ¡å®Œæˆç‡åˆ†åˆ«è¾¾åˆ°äº†98.0%ã€93.5%å’Œ64.0%ï¼Œæ˜¾è‘—è¶…è¶Šäº†ReActå’ŒLoTç­‰ç°æœ‰æœ€å…ˆè¿›çš„æ™ºèƒ½ä½“ï¼Œå±•ç¤ºäº†å…¶åœ¨è¯ç‰©å‘ç°ä¸­çš„å¼ºå¤§èƒ½åŠ›å’Œåº”ç”¨æ½œåŠ›ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

DrugPilotåœ¨è¯ç‰©å‘ç°é¢†åŸŸçš„æ½œåœ¨åº”ç”¨åœºæ™¯åŒ…æ‹¬æ–°è¯ç ”å‘ã€è¯ç‰©é‡å®šä½å’Œä¸´åºŠè¯•éªŒè®¾è®¡ç­‰ã€‚å…¶è‡ªåŠ¨åŒ–å’Œäº¤äº’å¼çš„æ•°æ®é›†æˆæ¨ç†èƒ½åŠ›ï¼Œèƒ½å¤Ÿæ˜¾è‘—æå‡ç§‘å­¦ç ”ç©¶çš„æ•ˆç‡å’Œå‡†ç¡®æ€§ï¼Œæ¨åŠ¨è¯ç‰©å‘ç°çš„è¿›ç¨‹ã€‚æœªæ¥ï¼ŒDrugPilotæœ‰æœ›æ‰©å±•åˆ°å…¶ä»–è®¡ç®—ç§‘å­¦é¢†åŸŸï¼Œä¿ƒè¿›æ›´å¹¿æ³›çš„ç§‘å­¦å‘ç°ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution. However, applying LLM agents to drug discovery is still constrained by challenges such as large-scale multimodal data processing, limited task automation, and poor support for domain-specific tools. To overcome these limitations, we introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific workflows in drug discovery. DrugPilot enables multi-stage research processes by integrating structured tool use with a novel parameterized memory pool. The memory pool converts heterogeneous data from both public sources and user-defined inputs into standardized representations. This design supports efficient multi-turn dialogue, reduces information loss during data exchange, and enhances complex scientific decision-making. To support training and benchmarking, we construct a drug instruction dataset covering eight core drug discovery tasks. Under the Berkeley function-calling benchmark, DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively. These results highlight DrugPilot's potential as a versatile agent framework for computational science domains requiring automated, interactive, and data-integrated reasoning.

